All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/r
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine On 30 January...
Brazilian National Institute of Industrial Property Rejects Truvada® Patent Application
On 24 January 2017, Brazil’s National Institute of Industrial Property (INPI) made public a decision to reject the patent application...
Patent on HIV and Hepatitis drug TAF challenged in Ukraine
On 28 December 2016, the All-Ukrainian Network of People Living with HIV/AIDS submitted a patent invalidation claim against Gilead patent...
Debating patent law and access to medicines in Ukraine
Last month (9 December 2016), the All-Ukrainian Network of People Living with HIV/AIDS held a roundtable meeting on ‘Patent Law...
Open Letter to WHO Director General, Margaret Chan
Civil Society Open Letter urging WHO to include UN High Level Panel on Access to Medicines Report on WHO Board Agenda
Thai Activists and Hospital Staff Review Progress on HCV Treatment
Community groups and government hospital staff from eight provinces met to review access to medicines on 15 and 16 November. The...
Access to Medicines, Medical Technologies and Human Rights Meeting
15 years of the Doha Declaration on TRIPS and Public Health: The meeting will examine health safeguards as effective tools...
Kyrgyzstan’s new patent law results in affordable life-saving drugs
In April 2015 Kyrgyzstan’s president took the necessary step of signing in a new patent law. This was the result...
Pressure leads to incorporation of new antiretroviral
The incorporation of a new antiretroviral in Brazil’s national treatment guidelines, and the scale up of a second-line treatment are...
Seminar: Policies around Access to Medicines & Human Rights
Watch the presentations of the "Sustainability, Health Systems and Human Rights" at the Seminar on Policies of Access to Medicines and Human Rights.